Population: People living with HIV

Individuals who have been diagnosed with human immunodeficiency virus (HIV) and may be receiving antiretroviral therapy to manage the condition

STD-MAR/Mpox

Spain
|
2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • PrEP users
  • People living with HIV
  • Hospital wide
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • JYNNEOS

Svartstein

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • People at high risk of STIs
  • Men who have sex with men
  • People living with HIV
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

MonVIP

France
|
2023
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

mpox-ICONA

Italy
|
2022-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • People living with HIV
  • Hospital wide
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

PISCIS

Spain
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Non-hospital health centre
  • Telemedicine
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination

MASH-1

United Kingdom France Spain Poland
|
2024-2024
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Kowalski

Poland
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • Men who have sex with men
  • People living with HIV
  • Hospital wide
  • Monkeypox virus
  • Mpox

DegliAntoni

Italy
|
2020-2022
  • Adults (18-64 years)
  • Fragile population
  • Immunocompromised host
  • People living with HIV
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Antinori

Italy
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • PrEP users
  • People living with HIV
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN